Targeting Peroxisome Proliferator-Activated Receptor-α (PPAR- α) to reduce paclitaxel-induced peripheral neuropathy is a research paper published in Brain Behavior and Immunity (2021). On theSindex it has a DataRank of 0. It has been cited 50 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01CA219637
VCU Massey Cancer Center
Grant: P30DA033934
NCATS NIH HHS
Grant: UL1 TR001863
National Institutes of Health
Grant: 5P30DA033934-09
The Central Virginia Center on Drug Abuse Research
National Institutes of Health
Grant: 1R01CA219637-01A1
(PQ12) Peroxisome proliferator-activated receptor alpha agonists as potential treatment for chemotherapy-induced peripheral neuropathy
FWCI
2.67
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals